Moroctocog alfa Completed Phase 4 Trials for Hemophilia A Treatment

IndicationsStatusPurposePhase
CompletedTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT00914459Study Evaluating Safety And Efficacy Of Moroctocog Alfa (AF-CC) In Previously Treated Hemophilia A Patients
NCT02492984PF-05208756, Moroctocog Alfa (AF-CC), Xyntha For Hemophilia A